Cargando…

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma

Background. The combination of topotecan and cyclophosphamide (TC) has activity in pediatric patients with recurrent sarcoma, especially Ewing's sarcoma (EWS). We sought to determine the toxicity of and response to TC in adults with recurrent sarcoma. Patients and Methods. Adults treated with T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanchette, P., Hogg, D., Ferguson, P., Wunder, J. S., Swallow, C., Gladdy, R., Chung, P., O'Sullivan, B., Blackstein, M. E., Catton, C., Gupta, A. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407653/ https://www.ncbi.nlm.nih.gov/pubmed/22851904 http://dx.doi.org/10.1155/2012/749067

Ejemplares similares

Clinical Features, Treatment, and Outcome in 102 Adult and Pediatric Patients with Localized High-Grade Synovial Sarcoma
por: Al-Hussaini, H., et al.
Publicado: (2011)

Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution Experience
por: Weiss, Kurt R., et al.
Publicado: (2011)

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2023)

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors
por: Vo, Kieuhoa T., et al.
Publicado: (2016)

Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study
por: Ribeiro, Mauricio Fernando, et al.
Publicado: (2023)

Recent Progress in the Management of Retroperitoneal Sarcoma
por: Cheifetz, Rona, et al.
Publicado: (2001)

Incidence and Severity of Lymphoedema following Limb Salvage of Extremity Soft Tissue Sarcoma
por: Friedmann, Daniel, et al.
Publicado: (2011)

Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
por: De Ioris, Maria Antonietta, et al.
Publicado: (2023)

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer
por: Riemsma, Rob, et al.
Publicado: (2010)

Topotecan in the treatment of relapsed small cell lung cancer
por: Quoix, Elisabeth
Publicado: (2008)

Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas
por: Wong, Philip, et al.
Publicado: (2015)

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
por: Ramaswamy, Kavitha, et al.
Publicado: (2022)

Long-Term Quality of Life of Retroperitoneal Sarcoma Patients Treated with Pre-Operative Radiotherapy and Surgery
por: Wong, Philip, et al.
Publicado: (2017)

Topotecan: An evolving option in the treatment of relapsed small cell lung cancer
por: Garst, Jennifer
Publicado: (2007)

Phase I Trial of Autologous Hematopoietic Stem Cell Transplantation with Escalating Doses of Topotecan Combined with Cyclophosphamide and Carboplatin in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma
por: Litzow, MR, et al.
Publicado: (2009)

Development of Genetically Flexible Mouse Models of Sarcoma Using RCAS-TVA Mediated Gene Delivery
por: Kabaroff, Leah, et al.
Publicado: (2014)

Evidence-based region of interest matching guidelines for sarcoma volumetric image-guided radiation therapy()
por: Li, Winnie, et al.
Publicado: (2018)

Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study
por: Angarita, Fernando A., et al.
Publicado: (2016)

A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
por: Chiappori, Alberto A., et al.
Publicado: (2016)

Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Evaluation of topotecan monotherapy for relapsed small-cell lung cancer after amrubicin monotherapy failure
por: Fujita, Kohei, et al.
Publicado: (2021)

Commentary: Periocular topotecan for retinoblastoma
por: Sharma, Minal, et al.
Publicado: (2018)

The Lipophilic Purine Nucleoside—Tdp1 Inhibitor—Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo
por: Chernyshova, Irina A., et al.
Publicado: (2022)

Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis
por: Imai, Hisao, et al.
Publicado: (2018)

A phase I and pharmacokinetic study of intraperitoneal topotecan
por: Hofstra, L S, et al.
Publicado: (2001)

Functional Outcome in Limb-Salvage Surgery for Soft Tissue Tumours of the Foot and Ankle
por: Colterjohn, Nigel R., et al.
Publicado: (1997)

Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI
por: Ingley, Katrina M., et al.
Publicado: (2019)

A Phase II Study of Docetaxel in Chemotherapy-Naïve Patients With Recurrent or Metastatic Adult Soft Tissue Sarcoma
por: Bramwell, Vivien, et al.
Publicado: (1998)

Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma
por: Francis, Jasmine H., et al.
Publicado: (2013)

Periocular topotecan for vitreous seeds in retinoblastoma
por: Sthapit, Purnima R, et al.
Publicado: (2018)

Tracking the cell cycle origins for escape from topotecan action by breast cancer cells
por: Feeney, G P, et al.
Publicado: (2003)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial
por: Manji, Arif, et al.
Publicado: (2022)

Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program
por: Veitch, Zachary W., et al.
Publicado: (2020)

Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience
por: Hagmann, Raphael, et al.
Publicado: (2015)

Optimization of liposomal topotecan for use in treating neuroblastoma
por: Chernov, Lina, et al.
Publicado: (2017)

Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Topotecan or other agents as second-line therapy for relapsed small-cell lung cancer: A meta-analysis of randomized studies
por: Petrelli, Fausto, et al.
Publicado: (2021)

Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study
por: Rujkijyanont, Piya, et al.
Publicado: (2019)

Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide.
por: Herben, V. M., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_plcndlj7t33i4g5njrgm0jnt0o